Hyaluronic Acid Market Size

Hyaluronic Acid Market size was valued at USD 9.4 Billion in 2023 and is poised to grow from USD 10.11 Billion in 2024 to USD 18.07 Billion by 2032, growing at a CAGR of 7.58% during the forecast period (2025-2032).

The Hyaluronic acid market is relatively fragmented, with a high level of competition. Few large players, like Allergan Inc., Sanofi S.A., and Anika Therapeutics, Inc., now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Allergan, Inc. ', 'Galderma', 'Salix Pharmaceuticals ', 'Lifecore Biomedical ', 'Anika Therapeutics, Inc. ', 'Seikagaku Corporation ', 'Fidia Farmaceutici S.p.A. ', 'Sanofi ', 'Zimmer Biomet ', 'Smith & Nephew plc ', 'Shiseido Company, Limited ', 'LG Chem ', 'Contipro a.s. ', 'Kewpie Corporation ', 'Maruha Nichiro Corporation ', 'HTL Biotechnology ', 'Bioiberica S.A.U. ', 'AbbVie Inc. ', 'Bohus BioTech AB ', 'Roche Holding AG'

The increased number of plastic surgeons and cosmetic clinics contributes to an increase in the number of aesthetic operations performed. The hyaluronic acid industry is being driven by the increasing use of nonsurgical cosmetic procedures such as Botox and hyaluronic acid injectables.

Increasing elderly population and the rising prevalence of obesity are the trends that have been witnessed in recent times that will benefit the hyaluronic acid market. Dermal fillers are the most common nonsurgical injectable procedures, and they are frequently used to fix soft tissue abnormalities on the face. This is according to the American Society of Plastic Surgeons (ASAPS). Dermal fillers made from hyaluronic acid are widely used for cosmetic purposes. These fillers are injected to smooth out wrinkles and creases, treat dark circles under the eyes, smooth out scars, and rejuvenate the skin. All these development is expected to propel the expansion of the hyaluronic acid market and will be bolstered throughout the forecast period.

In 2021, North America accounted for more than 43% of the global hyaluronic acid market and is expected to do the same throughout the analysis period. This is owing to the presence of a sizable older population, which is more vulnerable to illnesses like osteoarthritis, vesicoureteral reflux, and cataracts. Furthermore, the increased demand for less invasive aesthetic operations is a crucial element contributing to North America's high share.